Table 1.
“mastocytosis” [mesh] OR “osteoporosis” [mesh] OR “biphosfonates” [mesh] OR |
“Denosumab” [mesh] OR “IFN-alfa” [mesh] OR “Teriparatide” [mesh] OR |
“kyphoplasty” [mesh] OR “tyrosine kinase inhibitors” [mesh] OR “Dexa” [mesh] OR |
“fracture risk” [mesh] OR osteosclerosis [mesh] OR “zoledronate” [mesh] OR “serume trypsin” [mesh] OR “bone lesions, focal or multiple” [mesh] OR “osteopenia” [mesh] OR “bone marrow biopsy” [mesh] OR “mast cells” [mesh] OR “bone scintigraphy” [mesh] |